Target intelligence / Profile preview

Messenger RNA 3' untranslated regions (3'UTR)

Target
3'UTR
Molecular classification
RNA, Regulatory element, Nucleic acid
01

Overview

The messenger RNA 3' untranslated region (3'UTR) is the section of an mRNA molecule that follows the translation termination codon and precedes the poly(A) tail. These regions serve as critical hubs for post-transcriptional regulation, containing various cis-regulatory elements such as AU-rich elements (AREs) and binding sites for microRNAs (miRNAs) and RNA-binding proteins (RBPs) (Mayr, 2017). Through these interactions, 3'UTRs govern the stability, subcellular localization, and translation efficiency of the transcript (Barrett et al., 2012). Dysregulation of 3'UTR-mediated control, often through mutations or alternative polyadenylation, is implicated in numerous diseases, including cancer, where shortened 3'UTRs can lead to the overexpression of oncogenes by escaping miRNA-mediated repression (Passacantilli et al., 2017). In therapeutic development, 3'UTRs are targeted by antisense oligonucleotides (ASOs) and siRNAs to modulate protein production or induce transcript degradation, and they are increasingly explored as targets for small molecules designed to interfere with specific RNA-protein interactions (Crooke et al., 2021).

Other names
3'-untranslated region3'-UTRTrailer sequencemRNA 3'UTR3' untranslated region
02

Mechanism of action

Drugs targeting mRNA 3'UTRs typically function by binding to specific regulatory sequences to either promote RNA degradation (via RNase H or RNAi pathways) or to sterically hinder the binding of microRNAs and RNA-binding proteins, thereby modulating the stability and translation of the target message (Crooke et al., 2021).

03

Biological functions

Post-transcriptional gene regulationmRNA stabilityTranslation initiationmRNA localizationPolyadenylation
04

Disease associations

CancerNeurodegenerative diseaseGenetic disorderMetabolic disease
05

Safety considerations

Off-target hybridization effectsInnate immune activation (e.g., TLR7/8)Saturation of RNAi machineryDisruption of global RNA-binding protein stoichiometry
06

Interacting drugs

Antisense oligonucleotides (ASOs)

4 more in the full profile.

07

Biomarkers

mRNA expression levelsProtein expression levelsPoly(A) tail lengthAlternative polyadenylation (APA) patterns

Beyond the preview

Go deeper on Messenger RNA 3' untranslated regions (3'UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Messenger RNA 3' untranslated regions (3'UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call